FibroGen (FGEN) Tops Q1 EPS by 15c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of $0.05, $0.15 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $2.74 million versus the consensus estimate of $35.5 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• B.Riley on AMC Entertainment (AMC) earnings: 'Overall, we thought this was an encouraging report'
• ProLogis (PLD) PT Raised to $162 at Truist Securities
• DA Davidson Reiterates Buy Rating on Tractor Supply Company (TSCO) Amid Soft Q2 Expectations